Browsing by Author "Baladia, Eduard"

Now showing 1 - 4 of 4
  • Thumbnail Image
    Item
    Evaluación de la ingesta alimentaria: una reflexión que nos acerque al futuro
    (2021) Aguirre Polanco, Carolina; Bonilla, Diego A.; Almendra Pegueros, Rafael; Perez Lopez, Alberto; Gamero, Amparo; Santos Duarte Junior, Miguel Angelo dos; Peterman Rocha, Fanny; Lozano Lorca, Macarena; Camacho Lopez, Saby; Kammar Garcia, Ashuin; Durán Aguero, Samuel; Perez Esteve, Edgar; Fernandez Villa, Tania; Nava Gonzalez, Edna J.; Baladia, Eduard; Valera Gran, Desiree; Navarrete Munoz, Eva María
  • Thumbnail Image
    Item
    Overweight and obesity as potential prognostic factors for severity and mortality in patients with COVID-19: A living systematic review protocol
    (2020) Bonilla-Untiveros, Catherine; Camacho-López, Saby; Baladia, Eduard; Ortiz Muñoz, Luis Eugenio; Rada Giacaman, Gabriel Alejandro
    This living systematic review aims to provide a timely, rigorous and continuously updated summary about the impact of overweight or obesity as a prognostic factor for severity and mortality in patients with COVID-19. Design This is a protocol of a living systematic review. Data sources We will conduct searches in MEDLINE/PubMed, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), grey literature and in a centralized repository in L·OVE (Living OVerview of Evidence). L·OVE is a platform that maps PICO questions to evidence from Epistemonikos database. In response to the COVID-19 emergency, L·OVE was adapted to expand the range of evidence it covers and customised to group all COVID-19 evidence in one place. The search will cover the period until the day before submission to a journal. Eligibility criteria for selecting studies and methods We adapted an already published common protocol for multiple parallel systematic reviews to the specificities of this question. We will include all primary studies that assess patients with confirmed or suspected infection with SARS-CoV-2 and inform the relation of overweight or obesity with death or disease severity. Two reviewers will independently screen each study for eligibility, extract data, and assess the risk of bias. We will pool the results using meta-analysis and will apply the GRADE system to assess the certainty of the evidence for each outcome. A living, web-based version of this review will be openly available during the COVID-19 pandemic. We will resubmit it every time the conclusions change or whenever there are substantial updates.
  • No Thumbnail Available
    Item
    Vitamin C for COVID-19: A living systematic review
    (2020) Baladia, Eduard; Pizarro, Ana Beatriz; Ortiz Muñoz, Luis Eugenio; Rada Giacaman, Gabriel Alejandro
    Objective: This living systematic review aims to provide a timely, rigorous, and continuously updated summary of the available evidence on the role of vitamin C in treating patients with COVID-19.Data sources: We conducted searches in PubMed/MEDLINE, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), grey literature, and in a centralized repository in L·OVE (Living OVerview of Evidence). In response to the COVID-19 emergency, L·OVE was adapted to expand the range of evidence it comprises and has been customized to group all COVID-19 evidence in one place. All the searches covered the period until April 29, 2020 (one day before submission).Study selection and methods: We adapted an already published standard protocol for multiple parallel systematic reviews. We searched for randomized trials evaluating the effect, in patients with COVID-19, of vitamin C versus placebo or no treatment. Anticipating the lack of randomized trials directly addressing this question, we also searched for trials evaluating MERS-CoV and SARS-CoV, and non-randomized studies in COVID-19. Two reviewers independently screened each study for eligibility. A living, web-based version of this review will be openly available during the COVID-19 pandemic, and we will resubmit it to the journal whenever there are substantial updates.Results: We screened 95 records, but no study was considered eligible. We identified 20 ongoing studies, including 13 randomized trials evaluating vitamin C in COVID-19.Conclusions: We did not find any studies that met our inclusion criteria, and hence there is no evidence to support or refute the use of vitamin C in the treatment of patients with COVID-19. A substantial number of ongoing studies should provide valuable evidence to inform researchers and decision-makers soon.
  • Thumbnail Image
    Item
    Volver a lo básico: líneas estratégicas 2018
    (2017) Baladia, Eduard; Martínez-Rodríguez, Rodrigo; Navarrete-Muñoz, Eva María; Romá-Ferri, María Teresa; Olmedo-Requena, Rocío; Benítez Brito, Néstor; Soler, Carla; García de la Hera, Manuela; Dávila-Batista, Verónica; Aguirre Polanco, Carolina; Souza-Teixeira, Fernenada; Soares, Panmela